Publications
Overcoming resistance: targeting the PI3K/mTOR pathway in endocrine refractory breast cancer.
Abstract
Commentary to:: Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells: Euphemia Leung, Ji Eun Kim, Gordon W. Rewcastle, Graeme J. Finlay and Bruce C. Baguley.
Authors | Butt, A. |
---|---|
Publisher Name | CANCER BIOLOGY & THERAPY |
Published Date | 2011-06-01 |
Published Volume | 11 |
Published Issue | 11 |
Published Pages | 947-9 |
Status | Published in-print |
URL link to publisher's version | http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21577052 |
OpenAccess link to author's accepted manuscript version | https://publications.gimr.garvan.org.au/open-access/11040 |